|Articles|April 21, 2020

Contagion Live News Network: Coronavirus Updates for April 21, 2020

A daily COVID-19 update for Tuesday, April 21.

Hello and thanks for joining Contagion. I’m Grant Gallagher, here with a coronavirus update.

More than 1,300 inmates at three facilities in Ohio have tested positive for coronavirus, making the prison system a new hot spot for the outbreak in the United States.

Georgia, Tennessee, South Carolina and other states have been moving toward a gradual reopening of some businesses soon, while other states are likely to keep their economies shut down to the current level into May.

In other US political news, a deal between the parties seems close on extending the small business bailout which recently used up its full reserves.

On Contagion, we recently published an article concerning the Morale of Health Care Workers During Coronavirus, arguing that ensuring the best conditions and support possible for essential medical workers is necessary to best get us through the pandemic.

We also detailed the impact of social distancing in 4 major US cities, after a study was released which showed slowdowns in population movement at key points during the month of March.

For more on these stories and other infectious disease news, visit Contagionlive.com. Be sure to follow the spread of outbreaks across the globe with the Contagion outbreak monitor.

For Contagion, I’m Grant Gallagher.


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.